Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs

Author： Loscher W.   Leppik I.E.  

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.50, Iss.1, 2002-06, pp. : 17-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New horizons in the development of antiepileptic drugs

By Loscher W.   Schmidt D.  

Epilepsy Research, Vol. 50, Iss. 1, 2002-06 ,pp. : 3-16

Elsevier

Access to resources Recommend Favorite

The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics

By Holmes G.L.  

Epilepsy Research, Vol. 50, Iss. 1, 2002-06 ,pp. : 41-54

Elsevier

Access to resources Recommend Favorite

New antiepileptic drugs in the intractable epilepsies

By Gyouml rgy I.   Kulcsaacute r A.   Csuuml llouml gh Z.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 243-244

Elsevier

Access to resources Recommend Favorite

Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs

By Meldrum B.  

Epilepsy Research, Vol. 50, Iss. 1, 2002-06 ,pp. : 33-40

Elsevier

Access to resources Recommend Favorite

Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy

By Schmidt D.  

Epilepsy Research, Vol. 52, Iss. 1, 2002-11 ,pp. : 61-69

Elsevier

Access to resources Recommend Favorite